Align Technology Beats on Record Invisalign Shipments, Reaffirms FY2026 Guidance

Transcript intelligence

What changed

Q1 revenue reached $1.04 billion, up 6.2% YoY, with EPS of $2.58 versus $2.30 estimated (12.2% surprise). Record 686,000 Invisalign cases shipped, with higher ASPs contributing to revenue growth. Gross margin expanded to 70.8% GAAP and 71.8% non-GAAP, while operating margin improved to 13.6% GAAP and 21.5% non-GAAP. International markets (EMEA, APAC, Latin America) delivered double-digit growth, offsetting a modest North America slowdown. New product innovations including Invisalign First, the Pal Expander (IPE), the ART pilot, and Zero-AA/NOAA configurations contributed to margin expansion. The market reaction was negative: shares showed an abnormal decline of 2.3% versus the benchmark's positive move, on volume 1.88x the baseline.

Guidance delta

Management reaffirmed FY2026 guidance with a maintained sentiment. Capex outlook is increasing, with $125-150 million planned for FY2026 manufacturing capacity and technology upgrades. Share repurchases of up to $400 million are authorized for 2026. Management built in prudence for macro risks, particularly the Middle East conflict, but did not adjust the full-year outlook.

Key takeaways

• Q1 revenue of $1.04B and EPS of $2.58 beat consensus estimates on both lines, with EPS surpassing estimates by 12.2%.
• Record 686,000 Invisalign cases shipped, with higher ASPs contributing to revenue growth alongside volume.
• International markets (EMEA, APAC, Latin America) delivered double-digit growth, offsetting a modest North America slowdown.
• Gross margin expanded to 70.8% GAAP driven by higher ASPs, operational efficiencies, and lower refinement rates, with NOAA/Zero-AA configurations adding margin upside.
• Management reaffirmed FY2026 guidance while noting macro risks, especially the Middle East conflict, and committed to $400M in share repurchases and $125-150M in capex.
• A clinical study showed the Invisalign Pal Expander achieved results comparable to traditional Hyrax expanders, and the inaugural ART pilot launched in the U.S. with exocad integration.

Management priorities

• Launch DSP program in APAC in Q2 2026.
• Scale Zero-AA and NOAA configurations across more markets.
• Expand direct 3D printing of attachments and retainers.
• Broaden Invisalign Pay across additional Latin American countries.
• Continue disciplined share repurchases totaling up to $400 million in 2026.
• Invest $125-150 million in FY2026 capex for manufacturing capacity and technology upgrades.